Golden State Medical Supply Recalls Venlafaxine Hydrochloride Extended-Release Capsules
Golden State Medical Supply Inc. is recalling specific lots of Venlafaxine Hydrochloride Extended-Release Capsules, 150 mg, due to failed dissolution specifications.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe rating under the rubric, particularly for pharmaceutical products where efficacy is compromised.
Plain-English summary
Golden State Medical Supply Inc. is recalling specific lots of Venlafaxine Hydrochloride Extended-Release Capsules, 150 mg. The recall involves 65,401 bottles distributed nationwide. The affected products are identified by specific NDC numbers and lot numbers listed in the recall notice.
The recall was initiated because retained samples failed to meet dissolution specifications, resulting in out-of-specification results. This means the capsules may not release the medication as intended.
Consumers with these specific products should contact their healthcare provider or pharmacist for guidance on how to proceed. The recall is classified as FDA Class II.
The recalled product
- Product
- Venlafaxine Hydrochloride Extended-Release Capsules, 150 mg, a) 30 capsules per bottle, NDC # 60429-123-30, b) 90 capsules per bottle, NDC # 60429-123-90, Rx Only, GSMS.
- Manufacturer
- Golden State Medical Supply Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 65,401
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (15)
- Lot #: a) GS011931
- Exp 10/2017
- GS011932
- Exp 11/2017 b) GS010773
- GS011242
- 09/2017
- GS011061
- GS011315
- GS011357
- GS011585
- GS011586
- GS011588
- GS011591
- GS011933
- Exp 11/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 2 recalled by Golden State Medical Supply Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same manufacturer · Golden State Medical Supply Inc.
See all →- SevereGolden State Medical Supply Recalls Prasugrel Tablets for Failed Dissolution
FDA (Drugs) · 2026-09-09
- ModerateGolden State Medical Supply Recalls Carbamazepine Tablets Due to CGMP Deviations
FDA (Drugs) · 2026-08-26
- ModerateNiacin extended-release tablets failed dissolution testing at 24 hours
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- ModeratePrimidone Tablets Recalled Due to API Cross-Contamination
FDA (Drugs) · 2026-05-27
Same hazard · failed dissolution
See all →- ModerateInventia Recalls Chlorthalidone Tablets Due to Failed Dissolution Specifications
FDA (Drugs) · 2026-09-23
- ModerateMylan Recalls Prasugrel Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-09
- ModerateNovartis Recalls Diovan Valsartan Tablets Due to Failed Dissolution Specifications
FDA (Drugs) · 2026-08-19
- LowSupernus Recalls Trokendi XR Capsules for Failed Dissolution Specifications
FDA (Drugs) · 2026-07-29
- HighLannett niacin extended-release tablets failed dissolution specifications during stability
FDA (Drugs) · 2026-06-10
Similar recalls
- LowMcKesson Recalls Venlafaxine Hydrochloride Capsules for Dissolution Failure
FDA (Drugs) · 2014-03-26
- High
- ModerateZydus Recalls Venlafaxine Hydrochloride Capsules for Dissolution Failures
FDA (Drugs) · 2016-08-24
- ModerateVenlafaxine Extended-Release Capsules Recalled for Failed Dissolution
FDA (Drugs) · 2024-07-10
- ModerateCaraco Recalls Venlafaxine Hydrochloride Extended-Release Tablets for Dissolution Failures
FDA (Drugs) · 2014-05-07
- LowOsmotica Recalls Venlafaxine Extended Release Tablets for Dissolution Failure
FDA (Drugs) · 2013-10-09